A novel approach to screening for familial hypercholesterolemia in a large public venue

被引:24
作者
Campbell M. [1 ]
Humanki J. [1 ]
Zierhut H. [1 ]
机构
[1] Department of Genetics, Cell Biology, and Development, University of Minnesota—Twin Cities, 320 Church Street SE, 6-160 Jackson Hall, Minneapolis, 55455, MN
关键词
Cholesterol; Familial hypercholesterolemia; Genetic communication; Genetic information; Genetic screening; Genetic testing;
D O I
10.1007/s12687-016-0285-1
中图分类号
学科分类号
摘要
The primary aim of this study was to test the feasibility of a public health screening program to identify individuals at high risk of familial hypercholesterolemia through a novel screening approach at a large public venue. A finger-prick, non-fasting lipid panel was obtained, and a survey which consisted of 44 open- and close-ended questions divided into four sections: medical and family history of FH, opinions of cascade genetic testing, patient activation, and demographics was completed. A total of 971 participants met criteria and completed a cholesterol screen. In total, five individuals met either the Simon Broome Register or the Dutch Lipid Clinic Network criteria for possible familial hypercholesterolemia. Participants were generally positive towards genetic testing, and the vast majority listed they had no barriers to communication of genetic testing information to family members. However, the most common barrier listed was lack of communication skills. Our results suggest that a public health screening program for FH is viable at a large public venue. We argue that further research is needed to expand this study to a fully operational screening program. © 2016, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:35 / 44
页数:9
相关论文
共 38 条
[1]  
Andersen L.K., Jensen H.K., Juul S., Faergeman O., Patients’ attitudes toward detection of heterozygous familial hypercholesterolemia, Arch Intern Med, 157, pp. 553-560, (1997)
[2]  
Benn M., Watts G.F., Tybjaerg-Hansen A., Nordestgaard B.G., Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication, J Clin Endocrinol Metab, 97, pp. 3956-3964, (2012)
[3]  
Bensen J.T., Liese A.D., Rushing J.T., Et al., Accuracy of proband reported family history: the NHLBI Family Heart Study (FHS), Genet Epidemiol, 17, pp. 141-150, (1999)
[4]  
Risk Of Fatal Coronary Heart Disease In Familial Hypercholesterolaemia, BMJ, pp. 893-896, (1991)
[5]  
Forrest K., Simpson S., Wilson B., Et al., To tell or not to tell: barriers and facilitators in family communication about genetic risk, Clin Genet, 64, pp. 317-326, (2003)
[6]  
Gaff C.L., Collins V., Symes T., Halliday J., Facilitating family communication about predictive genetic testing: probands’ perceptions, J Genet Couns, 14, pp. 133-140, (2005)
[7]  
Go A.S., Mozaffarian D., Roger V.L., Et al., Heart disease and stroke statistics—2014 update: a report from the American Heart Association, Circulation, 129, pp. e28-e292, (2014)
[8]  
Goldberg A.C., Hopkins P.N., Toth P.P., Et al., Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia, J Clin Lipidol, 5, pp. S1-S8, (2011)
[9]  
Goldstein J., Hobbs H., Brown M., Familial hypercholesterolemia, (2001)
[10]  
Group. SSC on behalf of the SBR S.B.R., Risk of fatal coronary heart disease in familial hypercholesterolemia, BMJ, 303, pp. 893-896, (1991)